Cargando…
Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis
Crossing borders by treating a patient with difficult to treat XDR-TB; highly individualised but holistic approach http://ow.ly/JyjK30ielsD
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863047/ https://www.ncbi.nlm.nih.gov/pubmed/29419442 http://dx.doi.org/10.1183/13993003.02490-2017 |
_version_ | 1783308339411681280 |
---|---|
author | Akkerman, Onno W. Grasmeijer, Floris de Lange, Wiel C.M. Kerstjens, Huib A.M. de Vries, Gerard Bolhuis, Mathieu S. Alffenaar, Jan-Willem Frijlink, Henderik W. Smith, Grace Gajraj, Roger de Zwaan, Rina Hagedoorn, Paul Dedicoat, Martin van Soolingen, Dick van der Werf, Tjip S. |
author_facet | Akkerman, Onno W. Grasmeijer, Floris de Lange, Wiel C.M. Kerstjens, Huib A.M. de Vries, Gerard Bolhuis, Mathieu S. Alffenaar, Jan-Willem Frijlink, Henderik W. Smith, Grace Gajraj, Roger de Zwaan, Rina Hagedoorn, Paul Dedicoat, Martin van Soolingen, Dick van der Werf, Tjip S. |
author_sort | Akkerman, Onno W. |
collection | PubMed |
description | Crossing borders by treating a patient with difficult to treat XDR-TB; highly individualised but holistic approach http://ow.ly/JyjK30ielsD |
format | Online Article Text |
id | pubmed-5863047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-58630472018-03-23 Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis Akkerman, Onno W. Grasmeijer, Floris de Lange, Wiel C.M. Kerstjens, Huib A.M. de Vries, Gerard Bolhuis, Mathieu S. Alffenaar, Jan-Willem Frijlink, Henderik W. Smith, Grace Gajraj, Roger de Zwaan, Rina Hagedoorn, Paul Dedicoat, Martin van Soolingen, Dick van der Werf, Tjip S. Eur Respir J Agora Crossing borders by treating a patient with difficult to treat XDR-TB; highly individualised but holistic approach http://ow.ly/JyjK30ielsD European Respiratory Society 2018-03-22 /pmc/articles/PMC5863047/ /pubmed/29419442 http://dx.doi.org/10.1183/13993003.02490-2017 Text en Copyright ©ERS 2018 http://creativecommons.org/licenses/by-nc/4.0/ This ERJ Open article is open access and distributed under the terms of the Creative Commons Attribution Non-commercial Licence 4.0 |
spellingShingle | Agora Akkerman, Onno W. Grasmeijer, Floris de Lange, Wiel C.M. Kerstjens, Huib A.M. de Vries, Gerard Bolhuis, Mathieu S. Alffenaar, Jan-Willem Frijlink, Henderik W. Smith, Grace Gajraj, Roger de Zwaan, Rina Hagedoorn, Paul Dedicoat, Martin van Soolingen, Dick van der Werf, Tjip S. Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title | Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title_full | Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title_fullStr | Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title_full_unstemmed | Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title_short | Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
title_sort | cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis |
topic | Agora |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863047/ https://www.ncbi.nlm.nih.gov/pubmed/29419442 http://dx.doi.org/10.1183/13993003.02490-2017 |
work_keys_str_mv | AT akkermanonnow crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT grasmeijerfloris crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT delangewielcm crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT kerstjenshuibam crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT devriesgerard crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT bolhuismathieus crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT alffenaarjanwillem crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT frijlinkhenderikw crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT smithgrace crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT gajrajroger crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT dezwaanrina crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT hagedoornpaul crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT dedicoatmartin crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT vansoolingendick crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis AT vanderwerftjips crossborderhighlyindividualisedtreatmentofapatientwithchallengingextensivelydrugresistanttuberculosis |